Business Wire

Calvin Klein Fragrances announces ROSALÍA as the face of new euphoria elixirs

19.2.2026 14:30:00 CET | Business Wire | Press release

Share

Campaign fronted by the global superstar and brand ambassador explores the distinct universes of the three new parfums

Calvin Klein, Inc., part of PVH Corp. [NYSE: PVH], and Calvin Klein Fragrances, a division of Coty Inc. [NYSE: COTY], today unveil GRAMMY® Award-winning singer-songwriter ROSALÍA as the face of euphoria elixirs, a new collection of three distinct parfum intense creations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260219549836/en/

Calvin Klein Fragrances announces ROSALÍA as the face of new euphoria elixirs.

A daring new chapter of the iconic euphoria franchise, euphoria elixirs are a sensorial exploration of confidence, pleasure and sensuality. Embodied by global icon and Calvin Klein ambassador ROSALÍA, the campaign fuses movement and vivid color into a captivating exploration of freedom without limits. Known for her genre-defying sound and commanding visual artistry, ROSALÍA channels the fragrances’ modern femininity into an immersive journey that reflects the energy and individuality of the three distinctive scents.

“The euphoria elixirs are full of energy, possibility of expression and versatility!” said ROSALÍA. “Each of the three scents represents its own mood, but the vanilla notes (which I love) run through all of them, giving a warm and familiar feeling on the skin. This reunion with Calvin Klein has been a dream - I love working with teams that are as inspiring and hardworking as them!”

euphoria elixirs introduce premium, ultra-concentrations that celebrate the versatility of their key ingredient, vanilla – soft yet strong, sweet yet seductive. Richly layered and modern in spirit, the assortment takes shape through three vibrant, emotive interpretations: magneticelixir, bold elixir and solar elixir.

The euphoria elixirs collection:
Expressive. Radiant. Confident.

This collection explores vanilla—the fruit of the orchid, euphoria’s signature flower—through its full evolution from its fresh, green beginnings (solar elixir) to its vibrant ripeness (magnetic elixir), and finally to its sun-kissed, dried, and toasted warmth (bold elixir). Each scent pairs a distinct vanilla facet with a complementary note to define a clear mood: solar elixir fuses vanilla with mango for a bright, luminously joyful energy; magnetic elixir layers vanilla with musk for a soft, intimately romantic warmth; and bold elixir contrasts vanilla with oakwood for a deeper, more intense impression.

Co-created with master perfumers from some of the world’s most esteemed fragrance houses, all three scents are parfum intense with 28% or more ultra-concentration – the highest fragrance concentration for Calvin Klein Fragrances.

magnetic elixir (musky vanilla)
magnetic elixir captures the irresistible pull of effortless confidence and sensuality. Anchored by Dancing Lady Orchid, ambrette absolute and an indulgent musky vanilla blend, this rich, sweet fragrance has a seductive charm and lingers like a warm touch.

Perfumer: Caroline Dumur
Fragrance House: IFF

bold elixir (oakwood vanilla)
bold elixir is sensual, woody and addictive, channeling the intensity and rich depth of toasted vanilla. This warmth is contrasted by the unexpected presence of smoky orchid, rich oakwood and jasmine absolute. The result is a daring scent, exuding unapologetic confidence.

Perfumers: Carlos Benaim, Domitille Michalon, Caroline Dumur
Fragrance House: IFF

solar elixir (mango vanilla)
solar elixir is a radiant expression of joy – pure, luminous and full of life. Inspired by the blooming vanilla flower in its rare green and fruity stage, the fragrance is brightened by the warm glow of Golden Orchid and juicy mango. This elixir radiates with vibrant energy, evoking the sensation of skin warmed by the sun.

Perfumer: Nicolas Bonneville
Fragrance House: dsm-firmenich

The Packaging:
The original euphoria bottle remains a timeless, sculptural icon. For the new euphoriaelixirs, this classic design has been reinvented through color – vivid hues of magnetic pink, bold purple and solar yellow reflect youthful energy and individuality. The signature cap has also been infused with monochromatic color for a striking visual parallel to the intense juice.

The Campaign:
Following her Calvin Klein underwear debut in September 2025, ROSALÍA now stars in the Calvin Klein Fragrances campaign for euphoria elixirs, shot by Carlijn Jacobs. Across the visuals, ROSALÍA amplifies the spirit of euphoria – feminine, sensual and confident – through her unique ability to evoke emotion through movement and performance. Set in a surreal, sensorial world, ROSALÍA embodies each elixir’s distinct attitude across magnetic, bold and solar universes as unlimited possibilities of self-expression and freedom come to life.

Availability:
Calvin Klein euphoria elixirs will be available on calvinklein.com and retailers worldwide beginning February 19, 2026.

Available in 100 ml, 50 ml, 30 ml, and 10 ml.

Credits:
Campaign Video & Photographer: Carlijn Jacobs

Music Credits:
artist: ROSALÍA , song:“Dios Es Un Stalker” / album: LUX

Social Media:
@calvinklein

About Calvin Klein
Calvin Klein is one of the world’s leading global fashion lifestyle brands, founded in New York in 1968. Shaped by a way of living that meets culture, the brand’s distinctive, modern aesthetic informs its approach to iconic product design and influential brand storytelling.

Across underwear, jeans, apparel, accessories, home and fragrance, Calvin Klein creates essential pieces that translate its American fashion roots to an international audience. Global retail sales of Calvin Klein products were approximately $9 billion in 2024.

About PVH Corp.
PVH is one of the world’s largest fashion companies, driven by its two iconic brands, Calvin Klein and TOMMY HILFIGER. For more than 140 years, PVH has connected with and inspired consumers globally and now operates in more than 40 countries worldwide. For more information, visit https://www.pvh.com.

Follow us on Instagram and LinkedIn.

About COTY Inc.
Founded in Paris in 1904, Coty is one of the world's largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care. Coty serves consumers around the world, selling prestige and mass market products in over 120 countries and territories. Coty and our brands empower people to express themselves freely, creating their own visions of beauty; and we are committed to protecting the planet. Learn more at coty.com or on LinkedIn and lnstagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260219549836/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

GenBio AI Builds First World Model of the Human Cell18.8.2026 15:00:00 CEST | Press release

First-of-its-kind system simulates human cell behavior across the full biological hierarchy, from DNA and RNA through protein to the whole-cell level GenBio AI ('GenBio') is an AI for Science company co-founded by Nobel Laureate David Baker, leading AI scientist Eric Xing, and other prominent life science and artificial intelligence researchers from Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute, and other research institutions. Today, the company introduced AIDO Cell, its virtual cell world model — the first system capable of simulating a human cell, both in its natural state and in response to drugs and other interventions, across its full biological hierarchy, from DNA and RNA through protein to the whole-cell level. A Key First in Biological and Medical Sciences: Full-hierarchy virtual cell simulation has been widely identified as a key milestone in computational biology. Compared to the previous efforts by

Xsolla Partner Network Expands Verified Creator Partnerships and Unifies Campaign Management Ahead of gamescom 202618.8.2026 15:00:00 CEST | Press release

Developers Gain Vetted Creator Partnerships And A Single Campaign Workflow, Managed From The Publisher Account They Already Use Xsolla, a global video game commerce company, today announced an expansion of the Xsolla Partner Network ahead of gamescom 2026 in Cologne, giving game developers a simpler, more reliable way to grow their games through creators. The creator platform now lives within Xsolla Publisher Account, where developers already run their business, with verified creator onboarding and a redesigned and unified campaign workflow. Flat-fee campaigns, a new guaranteed payment option alongside revenue share, and data-driven creator recommendations are coming soon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818140062/en/ Graphic: Xsolla Xsolla Partner Network gives developers one place to launch, manage, track, and report on creator campaigns while Xsolla handles payments, payouts, taxes, and compliance.Verifi

KOCCA to Showcase 13 Korean Game Companies at ‘Gamescom 2026’ with PC, Mobile, and VR Lineups18.8.2026 14:48:00 CEST | Press release

- Featuring a diverse lineup of roguelike deckbuilders, AI-powered rhythm education, and cooperative horror games - Ranging from new titles based on the popular animated IP ‘LARVA’ to real-time K-POP dance coaching content - Hands-on experience available August 26–28 at the Korea Joint Pavilion B2B Hall, Koelnmesse, Booth Hall 3.2 C-050g–D051g The Korea Creative Content Agency (KOCCA) announced that 13 Korean game companies will gather under one roof at Gamescom 2026, Europe’s largest game show, held in Cologne, Germany, from August 26 to 28 (B2B, 09:00~20:00). Located in Booth Hall 3.2 C-050g–D051g, the Korea Joint Pavilion offers visitors hands-on experiences with an expansive lineup of titles, ranging from PC and mobile games to VR-powered titles across diverse genres. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818271881/en/ KOCCA will bring 13 Korean game companies to Gamescom 2026 in Cologne, Germany (Image: KOCC

SLB to Support Offshore Production Restoration for Brunei Shell Petroleum18.8.2026 14:06:00 CEST | Press release

Integrated execution model combines multiple disciplines to improve recovery from mature offshore assets Global energy technology company SLB (NYSE: SLB) today announced it has been awarded a contract by Brunei Shell Petroleum (BSP) to support production restoration from shut-in wells across multiple offshore fields. The contract scope spans subsurface evaluation, well candidate selection, engineering and offshore execution. Project management, intervention services, monitoring, metering and marine logistics are integrated within a single coordinated execution model designed to support efficient production restoration. “Building on our long collaboration in the region, this contract reflects a shared commitment to maximizing value from existing offshore resources,” said Gokhan Yarim, senior vice president of Integration, SLB. “Together with BSP, we are combining SLB’s production expertise and integrated execution capabilities to help restore production from shut-in wells, increase reco

BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries18.8.2026 12:00:00 CEST | Press release

Renewed collaboration builds on access provided to more than 300 patients with CLL to date and plans to support approximately 1,000 patients through 2028 BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, together with the BeOne Care Foundation, a nonprofit charitable foundation, and The Max Foundation, a leading global health nonprofit organization, today announced the renewal of their partnership through 2028 to expand access to BRUKINSA® (zanubrutinib) for the treatment of chronic lymphocytic leukemia (CLL) in low- and middle-income countries, with the program projected to support approximately 1,000 patients cumulatively. Building on a collaboration launched in 2023, the renewed partnership reflects the organizations’ shared commitment to improving access to innovative cancer treatments in underserved communities. To date, the partnership has enabled access to BRUKINSA for more than 300 patients with CLL across Armenia, Ethiopia, and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye